Even in people without high blood pressure, subclinical primary aldosteronism is linked to a significantly higher risk for ...

As Medicare turns 60, Medscape convened an expert panel to discuss the successes — and shortcomings — of this landmark ...

The European drug authority recommends refusal of marketing authorization after study shows no benefit over placebo.

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

As Medicare turns 60, Medscape convened an expert panel to discuss the use of AI in medicine, physician reimbursement, and ...

As Medicare turns 60, Medscape convened an expert panel to discuss if physicians can survive without the program and the ways ...

Preliminary data from clinical trials of tecovirimat as a treatment for mpox virus infection have given disappointing results ...

Biomarker panel based on capsule Cytosponge could simplify Barrett esophagus surveillance and reduce endoscopies in low-risk ...

In recently reported case studies, nemolizumab, approved for two indications associated with itch, has been reported to be ...

Nursing course applications in the UK have fallen 30% since 2021, prompting urgent calls for action to prevent further NHS ...

The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has adopted a positive opinion on ...